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As chronic inflammation is a hallmark of obesity,
pathways that integrate nutrient- and pathogen
sensing pathways are of great interest in under-
standing the mechanisms of insulin resistance, type
2 diabetes, and other chronic metabolic pathologies.
Here, we provide evidence that double-stranded
RNA-dependent protein kinase (PKR) can respond
to nutrient signals as well as endoplasmic reticulum
(ER) stress and coordinate the activity of other
critical inflammatory kinases such as the c-Jun
N-terminal kinase (JNK) to regulate insulin action
and metabolism. PKR also directly targets and
modifies insulin receptor substrate and hence inte-
grates nutrients and insulin action with a defined
pathogen response system. Dietary and genetic
obesity features marked activation of PKR in adipose
and liver tissues and absence of PKR alleviates
metabolic deterioration due to nutrient or energy
excess in mice. These findings demonstrate PKR
as a critical component of an inflammatory complex
that responds to nutrients and organelle dysfunction.
INTRODUCTION
Metabolic diseases appear as clusters including obesity, insulin
resistance, type 2 diabetes, and cardiovascular disease and
constitute a major global health problem with limited treatment
options. In the past decade, it has been realized that the emer-
gence of this cluster has strong inflammatory underpinnings
(Hotamisligil, 2006). During the course of obesity, a broad array
of inflammatory and stress responses are evoked in metabolic
tissues, leading to chronic, low-grade local inflammation that
plays a central role in the inhibition of insulin receptor signaling
and disruption of systemic metabolic homeostasis. This atypical
state, which we refer to as metaflammation (Hotamisligil, 2006),
involves immune and nonimmune cells and the engagement of338 Cell 140, 338–348, February 5, 2010 ª2010 Elsevier Inc.immune response pathways with nutrients and metabolites.
However, the mechanistic basis of these extensive functional
links and molecules that coordinate this network of responses
remains to be understood.
If the nutrient and pathogen response systems were truly inte-
grated, the involvement of pathogen sensors in metabolic regu-
lation, especially during exposure to excess nutrients, would be
anticipated. Such anticipation has stimulated the pursuit of
pattern recognition receptors (PRRs) such as the Toll-like recep-
tors (TLRs) for a role in metabolism (Shi et al., 2006). Other than
PRRs, there are only a few molecules that can assume such
a role to carry the potential ability for direct recognition of path-
ogens and possess catalytic activity to directly couple to meta-
bolic pathways. One such molecule is the double-stranded
RNA-dependent protein kinase (PKR), which has been originally
identified as a pathogen sensor and a proposed regulator of the
innate immune response against viral infections in higher eukary-
otes (Samuel, 1993). Virus-derived double-stranded RNA mole-
cules are recognized and bound by PKR through the N-terminal
double-stranded RNA-binding motifs, resulting in autophos-
phorylation through the activation of the intramolecular kinase
domain (Garcia et al., 2006; Williams, 2001). Interestingly, in
the context of infections, PKR can regulate or act in conjunction
with major inflammatory signaling pathways that are implicated
in metabolic homeostasis, including the c-Jun N-teminal kinase
(JNK) and IkB kinase (IKK) (Bonnet et al., 2000; Goh et al., 2000;
Takada et al., 2007). In metabolic disease, it is unclear how these
and other inflammatory signaling molecules are coordinately
regulated to disrupt metabolism. However, it is feasible to
consider a model where these multiple signaling pathways act
in concert by forming a response node or acting in complexes
that yield to metabolic surplus.
Interestingly, among the very few substrates identified for the
kinase activity of PKR, the major one is the eukaryotic initiation
factor 2a (eIF2a), which regulates general protein synthesis (Hol-
cik and Sonenberg, 2005; Ron and Walter, 2007). It has been
postulated that PKR-mediated phosphorylation of eIF2a is
a strategy to inhibit viral protein synthesis in host cells (Holcik
and Sonenberg, 2005). However, in other contexts, inhibition of
general translation through the same eIF2a phosphorylation
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Figure 1. Regulation of PKR Activity in Obesity and
Lipid Exposure
(A) A genetic mouse model of obesity (ob/ob) was used to
examine PKR activity by a kinase assay using immunopuri-
fied PKR and 32P-gATP in white adipose tissue (WAT) and
liver compared with age- and sex- matched lean controls.
Fatty acid synthase (FAS) and b-tubulin proteins are
shown as controls.
(B) PKR activity was examined in white adipose tissue
(WAT) and liver of the male WT mice kept either on regular
diet (RD) or high-fat diet (HFD) for 20 weeks.
(C) PKR activity in liver of 10-week-old male WT mice,
which were infused with lipid or saline for 5 hr. Total S6
protein is shown as control.
(D) PKR activity in primary MEFs. Cells were cultured in the
absence or presence of 0.5 mM palmitic acid for 2 hr.
See also Figure S1.represents a major arm controlling endoplasmic reticulum (ER)
homeostasis (Ron and Walter, 2007). ER stress also plays an
important role in the development of insulin resistance and
diabetes, at least in part, by triggering JNK activity (Gregor
and Hotamisligil, 2007; Ozcan et al., 2004). In both mouse
and human, there is a consistent and marked increase in
phosphorylation of eIF2a and JNK activity in obese metabolic
tissues (Gregor et al., 2009). Hence, coordination of protein
synthesis through eIF2a and stress signaling through JNK likely
represent a relevant mechanism in the integration of inflamma-
tory signals with metabolic outcomes, especially in the context
of nutrient and energy surplus. PKR features properties to coor-
dinate pathogen responses, endoplasmic reticulum function,
inflammatory signaling, and translational regulation. Therefore,
we postulate that PKR may represent a core component of
a putative ‘‘metabolic inflammasome,’’ in other words, a mecha-
nism integrating pathogen response and metabolic pathways
that plays a critical role in metabolic homeostasis by controlling
the action of major players such as JNK, IKK, and/or other
mediators.
RESULTS
PKR Activity in Obesity and Metabolic Stress
If PKR were involved in nutrient-induced inflammatory
responses, it would be anticipated that its activity is altered in
conditions of nutrient surplus. To explorewhether PKR activation
is altered in obesity and metabolic stress, we first examined
amodel of severe genetic obesity and insulin resistance resulting
from leptin deficiency (ob/ob, also known as Lepob/ob). There
was a striking increase in PKR activity, which was assessed by
autophosphorylation level of PKR using 32P-gATP, in both white
adipose tissue (WAT) and liver of ob/ob mice compared to leanCell 140, 33controls (Figure 1A). Similarly, there was a signif-
icant upregulation of PKR activity in both WAT
and liver tissues of mice fed with a high-fat diet
(Figure 1B). In both models, we also observed
an increase in PKR protein and mRNA levels,
consistent with the reported autoregulation of
PKR expression upon stimulation of its activity(Figures 1A and 1B and Figures S1A and S1B available online)
(Gusella et al., 1995; Samuel, 1993). However, there was only
a minor regulation of skeletal muscle tissue PKR activity in the
ob/ob model and no regulation was evident in dietary obesity
(Figures S1C and S1D). In adipose tissue, the principle source
of increased PKR expression in dietary obesity was found in
mature adipocyte fraction instead of stromal-vascular (SV) frac-
tion (Figure S1A). Interestingly, in addition to PKR itself, mRNA
levels of some other interferon target genes were also increased
in adipocytes of obese WAT and liver (Figures S1A and S1B). As
these mice were maintained in a specific pathogen-free environ-
ment, activation of PKR likely involves metabolic signals associ-
ated with nutrient and energy excess.
To determine whether PKR activity is related to metabolic
stress and triggered by a nutrient, we next used an in vivo lipid
infusion system, which acutely increases circulating free fatty
acids (FFA) and causes insulin resistance (Kim et al., 2004;
Shi et al., 2006). In this setting, there was also a significant
increase in PKR activity in lean mice following lipid exposure
(Figure 1C). These results demonstrate that PKR is activated
by nutrient excess and metabolic stress in vivo. Given that
PKR activity is induced by lipid infusion, we next explored
whether FFA itself can also activate PKR by treating primary-
isolated mouse embryonic fibroblast cells (MEFs) with palmitic
acid. As shown in Figure 1D, palmitic acid exposure resulted in
PKR activation. Since TLR4 has been implicated in fatty acid
response (Shi et al., 2006), we asked whether PKR activation
by lipids involved this PRR. However, in TLR4-deficient primary
MEFs, palmitic acid-induced PKR activation was also detected
at levels similar to those in wild-type (WT) controls (Figure S1E).
These experiments demonstrated that PKR is activated by
lipids in vitro and in vivo, and this activation is not dependent
on TLR4.8–348, February 5, 2010 ª2010 Elsevier Inc. 339
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Figure 2. PKR Regulates JNK Activity Resulting in Inhibition of Insulin Signaling
(A) Primary Pkr+/+ and Pkr/MEFs were treated with 0.5 mM palmitic acid for 2 hr. JNK activity was assessed by a kinase assay using recombinant c-Jun protein
as substrate.
(B) Induction of JNK phosphorylation after 300 nM thapsigargin (TG) treatment for 1 hr in primaryPkr+/+ andPkr/MEFs. Phosphorylation level of JNKwas exam-
ined with anti-phospho-JNK (Thr183/Tyr185) antibody.
(C and D) Induction of IRS1 phosphorylation after 0.5 mM palmitic acid (C) or 300 nM thapsigargin (D) treatment for 2 hr in Pkr+/+ and Pkr/ MEFs. Phosphor-
ylation level of IRS1 on Ser307 was examined with anti-phospho-IRS1 (serine 307) antibody.
(E) Induction of IRS1 phosphorylation in retrovirally PKR-reconstituted Pkr/MEFs. The cells were serum-starved for 14 hr followed by western blot analysis with
anti-phospho-IRS1 (serine 307) antibody.
(F) The PKR-reconstituted Pkr/MEFs were stimulated with 10 nM insulin for 3 min. The cell lysates were immunoprecipitated with anti-IRS1 antibody followed
bywestern blot analysis with anti-phospho-tyrosine and anti-PI3K (p85 subunit) antibodies. The graph on the right shows the quantification of the results. Data are
shown as the mean ± standard error of the mean (SEM). *p < 0.05.
(G and H) Induction of palmitic acid- and thapsigargin-induced PKR activity requires intact RNA-binding domain of PKR. Pkr/ MEFs were reconstituted with
vector, flag-tagged wild-type (WT), RNA-binding domain mutant (K64E), or kinase-deadmutant (K296R) of PKR by retrovirus-mediated gene transfer. These cells
weremaintained in serum-free DMEMcontaining 0.5%BSA for 14 hr followed by treatment with 0.5mMpalmitic acid for 90min (G) or 300 nM thapsigargin for 1 hr
(H). The cell lysates were immunoprecipitated with anti-Flag antibody followed by PKR kinase assay and western blot analysis with anti-Flag antibody.
See also Figure S2.PKR Controls JNK Activity in Response to Metabolic
Stress
JNK activity is modulated by PKR under several stress condi-
tions (Goh et al., 2000). As JNK activation is also related to fatty
acid exposure and ER stress (Gao et al., 2004; Urano et al., 2000)
and critical for insulin sensitivity (Hirosumi et al., 2002), we next
examined the impact of PKR on fatty acid- and ER stress-medi-
ated JNK activation. To assess effects of PKR deficiency in cells,
we elected to useMEFs frommice with a targetedmutation lack-
ing the PKR kinase domain (Abraham et al., 1999). Treatment of
these PKR-deficient (Pkr/) andWT (Pkr+/+) control primary-iso-
lated MEFs with palmitic acid demonstrated that this fatty acid
failed to activate JNK in the absence of PKR (Figure 2A). In
a similar fashion, treatment of Pkr+/+ and Pkr/MEFs with thap-
sigargin, an agent that induced ER stress, resulted in prominent
induction of JNK phosphorylation in Pkr+/+ relative to Pkr/ cells
(Figure 2B). ER stress-induced PKR activation was decreased in
the presence of translation inhibitor cycloheximide. Therefore,
new protein synthesis, at least in part, appears to be required340 Cell 140, 338–348, February 5, 2010 ª2010 Elsevier Inc.for PKR activation during ER stress (Figure S2A). Taken together,
these results demonstrate that PKR is a required component for
JNK activation in response to lipid exposure and ER stress.
One mechanism by which JNK negatively regulates insulin
signaling is through induction of IRS1 serine phophorylation in
response to fatty acid exposure and ER stress (Gao et al.,
2004; Ozcan et al., 2004). If PKR controls JNK activation, it is
conceivable that PKR may, indirectly or directly, target IRS1
function, which is critical in insulin action. To address whether
fatty acid- or ER stress-induced IRS1 phosphorylation is depen-
dent on PKR, we examined the effect of palmitic acid or thapsi-
gargin treatment on IRS1 serine phosphorylation in Pkr+/+ and
Pkr/ MEFs. Both of these treatments resulted in induction of
IRS1 serine 307 phosphorylation in Pkr+/+ MEFs but not in
Pkr/ cells (Figures 2C and 2D). As these data suggest that
activated PKR modulates IRS1 serine phosphorylation, we
next assessed the effect of a direct PKR activator, a virus-
derived double-stranded RNA mimetic, polyinosinic-polycyti-
dylic acid (polyIdC) (Garcia et al., 2006; Williams, 2001), on
IRS1 phosphorylation in Pkr+/+ and Pkr/MEFs. This treatment
also induced IRS1 serine phosphorylation with a marked
increase in PKR expression in Pkr+/+ MEFs. However, polyId
C-induced IRS1 phosphorylation was not observed in Pkr/
MEFs (Figure S2B). We also reconstituted PKR expression in
the Pkr/ MEFs as increased PKR expression itself induces
PKR activity thus allowing comparisons in the same cellular
background without stimulation of other signaling pathways
(Figure S2C). As shown in Figure 2E, serine phosphorylation of
IRS1 was induced by reconstitution of PKR in Pkr-deficient cells.
In these cells, the level of insulin-induced tyrosine phosphoryla-
tion of IRS1 and insulin-induced interaction between IRS1 and
p85, a regulatory subunit of phosphoinositide 3-kinase (PI3K),
were both significantly diminished in PKR-reconstituted cells
compared to the Pkr/ controls expressing the empty vector
(Figure 2F). Hence, PKR can induce IRS serine phosphorylation
and block insulin action.
We next asked whether RNA-binding ability of PKR is required
for palmitic acid- or ER stress-induced PKR activation. RNA-
binding capacity of PKR is abolished by introducing a point
mutation to its lysine 64 residue in the RNA-binding motif
(McCormack et al., 1994; Wu and Kaufman, 1996). We reconsti-
tuted Pkr/ MEFs with WT or RNA-binding defective (K64E)
PKR by retrovirus-mediated gene transfer and examined PKR
kinase activity after treatment with palmitic acid or thapsigargin.
Wild-type PKR is activated by both palmitic acid and thapsigar-
gin (Figures 2G and 2H). However, PKR with defective RNA
binding (K64E) was not activated in palmitic acid- or thapsigar-
gin-treated cells (Figures 2G and 2H). A mutation in the kinase
domain of PKR abolished all activity and was used as a control
(Figures 2G and 2H). These data demonstrate that PKR is
a required component for JNK activation and IRS1 inhibition
when induced by a nutrient, a pathogen component, or ER
stress, and the RNA-binding domain of PKR is indispensable in
both responses.
IRS1, a Direct Substrate of PKR
We next treated Pkr+/+ and Pkr/ cells with TNF-a, which is well
known to both induce PKR activity and block insulin action
through IRS1 phosphorylation in WT cells (Hotamisligil et al.,
1996). In these experiments, we noticed that PKR was detect-
able by western blot analysis following immunoprecipitation
with an anti-IRS1 antibody, demonstrating a potential interaction
between these proteins (Figure 3A). To verify the interaction
between PKR and IRS1, we next performed the reciprocal exper-
iment, where we immunoprecipitated PKR from protein extracts
of TNF-a-treated Pkr+/+ MEFs and attempted to detect IRS1 by
western blot analysis. PKR-deficient cells were used in the
same setting as controls. These experiments also demonstrated
the interaction between these two proteins (Figure 3B). To
assess the specificity of PKR-IRS1 interaction, we also exam-
ined the relation between IRS1 and the PKR-like endoplasmic
reticulum kinase (PERK), which is the closest homolog of PKR
in mammals, and did not detect any interaction between these
proteins with or without induction of ER stress (Figure S3).
We next performed an in vitro pull-down assay using recombi-
nant IRS1 and PKR proteins. These experiments demonstrated
that PKR directly interacts with IRS1 protein (Figure 3C). Therobust interaction between PKR and IRS1 raised the possibility
that PKR phosphorylates IRS1 directly. To address this possi-
bility, we performed kinase assays using recombinant IRS1
and active PKR in vitro. As shown in Figure 3D, PKR directly
phosphorylates IRS1 including the serine 307 residue. We next
performed in vitro kinase assays after immunopurification of
PKR from Pkr+/+ MEFs and used Pkr/ cell extracts as a nega-
tive control. We found that IRS1 was phosphorylated by immu-
nopurified PKR from TNF-a- or thapsigargin-treated Pkr+/+
MEFs (Figures 3E and 3F). More importantly, the increased
serine phosphorylation of IRS1, which is detected by a phos-
pho-specific antibody, was induced only by activated PKR
(Figures 3E and 3F). Again, the induction of IRS1 phosphorylation
was not observed in extracts prepared from TNF-a- or thapsigar-
gin-treated Pkr/ cells in control experiments (Figures 3E and
3F). We have previously shown that JNK1 plays a critical role
in stress-induced IRS1 phosphorylation and insulin resistance
(Hirosumi et al., 2002). To address whether JNK1 is required
for PKR-mediated IRS1 phosphorylation, we next assessed
effects of exogenous expression of PKR on IRS1 phosphoryla-
tion in primary Jnk1+/+ and Jnk1/ MEFs. By introducing PKR
through adenovirus-mediated gene transfer, serine phosphory-
lation of IRS1 is dramatically increased in Jnk1+/+ MEFs
(Figure 3G). In Jnk1/ MEFs, PKR still retained the ability to
induce serine phosphorylation of IRS1 (Figure 3G), although
this was significantly reduced in magnitude. These data suggest
that PKR assumes a role in regulation of IRS1 phosphorylation in
both a JNK1-dependent and -independent manner in cultured
cells and illustrate the importance of functional interaction
between these kinases to interfere with insulin action.
Metabolic Regulation and Insulin Action in Pkr/ Mice
Given that PKR activity is strongly regulated in obesity and linked
to signaling pathways interfering with metabolic homeostasis,
we then used several different in vivo models to test the func-
tional significance of PKR in the pathogenesis of obesity, insulin
resistance, and type 2 diabetes. First, mice lacking PKR (Pkr/)
and WT control (Pkr+/+) were placed on a high-fat diet (HFD)
along with a control group of each genotype on regular diet
(RD). The PKR-deficient model used in our study was generated
by removing the kinase domain and hence retains no kinase
activity (Abraham et al., 1999). On HFD, Pkr+/+ mice developed
obesity compared to mice kept on RD, while weight gain in
Pkr/ mice was significantly lower, starting to become evident
after 10 weeks of HFD (Figure 4A). Dual energy X-ray absorption
(DEXA) analysis demonstrated reduced total body adipose mass
in Pkr/ mice (Figure 4B). In addition, consistent with reduced
adiposity, serum leptin level in Pkr/ mice was lower than that
in Pkr+/+ mice (Figure 4C). Total serum adiponectin levels were
not significantly different between genotypes (Figure 4D). In
Pkr/ mice, blood glucose levels were significantly lower than
those in Pkr+/+ controls (Figure 4E). Examination of serum insulin
levels revealed that the hyperinsulinemia observed in Pkr+/+mice
was not evident in the Pkr/ animals, indicating that these
animals might exhibit enhanced insulin sensitivity (Figure 4F).
To investigate systemic insulin sensitivity, we performed glucose
tolerance tests (GTT) in Pkr/ and Pkr+/+mice at 6 and 14weeks
after the start of HFD. Since body weights of Pkr+/+ and Pkr/Cell 140, 338–348, February 5, 2010 ª2010 Elsevier Inc. 341
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Figure 3. PKR Directly Regulates IRS1 Phosphorylation
(A) Induction of interaction between IRS1 and PKR after TNF-a treatment in Pkr+/+ and Pkr/ MEFs. IRS1 and PKR protein levels were examined either with
immunoprecipitation (IP) followed by immunoblotting (IB) or by direct immunobloting in cells treated with 5 ng/ml TNF-a treatment for 3 hr.
(B) Physical interaction between IRS1 and PKR in TNF-a-treated MEF cells. Cell lysates were prepared from Pkr+/+ or Pkr/MEFs treated with 5 ng/ml TNF-a for
3 hr followed by immunoprecipitation with anti-PKR antibody and western blot analysis with anti-IRS1 antibody.
(C) Physical interaction between IRS1 and PKR in a pull-down assay in vitro using recombinant IRS1 and PKR proteins.
(D) Direct phosphorylation of IRS1 by PKR in kinase assay in vitro using recombinant IRS1 and PKR proteins. Phosphorylation level of IRS1 was assessed by
autoradiography or western blot analysis with anti-phospho-IRS1 (serine 307) antibody.
(E and F) In vitro PKR kinase assay. IRS1 phosphorylation by immunopurified PKR prepared from 5 ng/ml TNF-a (E) or 300 nM thapsigargin (F) treated MEFs and
analyzed by autoradiography or western blot analysis with anti-phospho-IRS1 (serine 307) antibody.
(G) Effects of exogenous expression of PKR on IRS1 serine phosphorylation in primary Jnk1+/+ and Jnk1/ MEFs. Flag-tagged human PKR was introduced to
primary Jnk1+/+ and Jnk1/ MEFs by adenovirus-mediated gene transfer. Phosphorylation level of IRS1 on serine 307 was examined with anti-phospho-IRS1
(serine 307) antibody. Both exogenous and endogenous PKR expression was detected by anti-PKR antibody. The graph on the right shows the quantification of
the data.
See also Figure S3.mice did not exhibit significant differences until week 10–12,
experiments performed at an early stage allowed evaluation of
insulin sensitivity without changes in body weight. After 6 weeks
of HFD, where the body weights were similar between geno-
types, Pkr/ mice already showed significantly lower glucose
levels after a glucose challenge compared to Pkr+/+ mice (Fig-
ure 4G). This increased glucose tolerance continued to be
evident in Pkr/mice after 14 weeks of HFD (Figure S4A). Simi-
larly, during insulin tolerance tests (ITT), the hypoglycemic
response to insulin was also significantly enhanced in Pkr/
mice compared to Pkr+/+ controls after 16 weeks of HFD (Fig-
ure S4B). Glucose disposal curves and the hypoglycemic
response to insulin in mice on RD were similar between geno-
types (Figures S4C and S4D). Although no significant changes
were observed in heat production, food intake, or total physical342 Cell 140, 338–348, February 5, 2010 ª2010 Elsevier Inc.activity between genotypes (Figures S4E–S4H), rates of oxygen
consumption and carbon dioxide production of Pkr/ mice
were modestly but significantly higher than those of Pkr+/+
mice (Figures S4I and S4J), indicating that energy expenditure
may be a potential mechanism for body weight reduction.
Biochemical and Molecular Alterations in Pkr/ Mice
Wenext studiedwhether deficiency of PKR resulted in enhanced
insulin action by examining in vivo insulin receptor-signaling
capacity in WAT and liver tissues of mice on HFD. In intact
animals, insulin-stimulated AKT phosphorylation on serine 473
was significantly increased in WAT extracts of Pkr/ mice
compared with those of Pkr+/+ controls (Figure 5A). There was
also significantly increased insulin-stimulated AKT phosphoryla-
tion in liver tissue of Pkr/ mice (Figure 5B). On the other hand,
Pkr−/−
A
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p
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Figure 4. Glucose Metabolism and Insulin Sensitivity in Pkr/ Mice
(A) Total bodyweight on regular (RD) or high-fat (HFD) diet. Obesity is induced byHFD starting immediately after weaning at 3 weeks of age. Data are shown as the
mean ± SEM. *p < 0.05.
(B) Analysis of body fat by dual energy X-ray absorptiometry (DEXA). Data are shown as the mean ± SEM. *p < 0.05.
(C and D) Serum leptin (C) and adiponectin (D) levels after 6 hr daytime food withdrawal in Pkr+/+ (n = 5) and Pkr/ (n = 6) mice on HFD for 15 weeks. Data are
shown as the mean ± SEM.
(E and F) Blood glucose (E) and serum insulin (F) levels after 6 hr daytime food withdrawal in Pkr+/+ (n = 6) and Pkr/ (n = 6) mice on HFD for 8 weeks. Data are
shown as the mean ± SEM.
(G) Glucose tolerance tests were performed on Pkr+/+ (n = 6) and Pkr/mice (n = 6) on RD and HFD for 6 weeks. Data are shown as the mean ± SEM. *p < 0.05.
See also Figure S4.we did not observe significant alterations in insulin signaling in
the skeletal muscle of Pkr/ mice (Figure S5A). These results
demonstrate significant contribution of PKR to high-fat diet-
induced insulin resistance. As eIF2a is a substrate of PKR, we
determined the phosphorylation level of eIF2a on Ser52 using
a specific antibody. These experiments demonstrate markedly
decreased eIF2a phosphorylation in both adipose tissue and
liver extracts of Pkr/ mice compared with those of Pkr+/+
controls (Figures 5C and 5D). Dietary obesity is also character-
ized by increased JNK activity (Hirosumi et al., 2002), which is
correlated with PKR activity (Figure 1). In liver and adipose
tissues, JNK1 activity was significantly reduced in Pkr/ mice
compared with Pkr+/+ controls on HFD (Figures 5C and 5D and
Figure S5B). These biochemical alterations were also reflected
in the expression of inflammatory mediators induced by obesity
in adipose tissue. In Pkr/ mice, expression levels of several
inflammatory cytokines such as Tnfa, Il6, and Il1b, and an anti-
inflammatory cytokine Il10, a potential target of PKR (Chakrabarti
et al., 2008), were significantly reduced in comparison to levels
seen in Pkr+/+ controls on HFD (Figure 5E). In addition, expres-sion of a macrophage marker F4/80 and an ER stress marker
Grp78 was also significantly reduced in adipose tissue of Pkr/
mice (Figure 5E). These changes in gene expression between
genotypes were not observed in mice fed RD (Figure S5C).
Consistent with the HFD-induced changes in inflammatory
gene expression, examination of the WAT sections revealed
reduced inflammatory cells in Pkr/ mice compared to Pkr+/+
controls (Figure 5F). There was also a reduction in hepatic fatty
infiltration (Figure 5G). Biochemical measurement of liver triglyc-
erides demonstrated the reduction in liver lipid content in Pkr/
mice (Figure 5H). Serum alanine aminotransferase (ALT) level
was not significantly different between genotypes (Figure 5I).
A Role of PKR in Lipid Infusion-Induced Acute Insulin
Resistance
As shown in Figure 1, lipid exposure leads to PKR activation.
To further explore the impact of PKR on insulin sensitivity in
another setting and without the potential confounding effects
of body weight or adiposity, we studied the effects of PKR
activation on acute insulin resistance induced by lipidsCell 140, 338–348, February 5, 2010 ª2010 Elsevier Inc. 343
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Figure 5. Biochemical and Molecular Alterations in Pkr/ Tissues
(A and B) Phosphorylation level of Akt on serine 473 in WAT (A) and liver (B) of Pkr+/+ and Pkr/mice on HFD for 20 weeks. The graphs on the right of each blot
show the quantification of the results. Data are shown as the mean ± SEM. *p < 0.05, **p < 0.01. AU: arbitrary unit.
(C and D) Phosphorylation level of eIF2a on serine 52 and JNK1 kinase activity, whichwas detected by a kinase assay using immunopurified JNK1, 32P-gATP, and
recombinant c-Jun protein as substrate in WAT (C) and liver (D) of Pkr+/+ and Pkr/ mice on HFD for 20 weeks. b-tubulin is shown as a control.
(E) Gene expression in WAT including proinflammatory cytokine levels in Pkr+/+ and Pkr/ mice on HFD for 20 weeks. Data are shown as the mean ± SEM.
*p < 0.05, **p < 0.01.
(F and G) Haematoxylin and eosin staining of WAT (F) and liver (G) sections of Pkr+/+ and Pkr/ mice, respectively. Scale bar, 200 mm.
(H) Triglyceride contents in liver of Pkr+/+ (n = 6) and Pkr/ (n = 6) mice on HFD for 20 weeks. Data are shown as the mean ± SEM.
(I) Serum alanine aminotransferase level after 6 hr daytime food withdrawal in Pkr+/+ (n = 6) and Pkr/ (n = 6) mice on HFD for 15 weeks. Data are shown as the
mean ± SEM.
See also Figure S5.(Shi et al., 2006). In this system, we administered lipid intrave-
nously into the Pkr+/+ and Pkr/ mice on RD and performed
hyperinsulinemic-euglycemic clamp studies to examine the
whole-body insulin sensitivity and glucose metabolism. Glucose
infusion rates (GIR) during the clamp studies indicated thatPkr/
mice required significantly higher levels of glucose infusion to
maintain blood glucose consistent with increased insulin sensi-
tivity (Figure 6A). In Pkr+/+ mice, GIR required to maintain eugly-
cemia was reduced by 50.2% in comparison with saline-infused
controls (Figure 6B). In contrast, lipid infusion exerted a signifi-
cantly smaller effect on the GIR in Pkr/ mice (Figure 6B).
Consistent with this result, the whole-body glucose disposal
rates (Rd) observed in Pkr/mice during the clamp were signif-344 Cell 140, 338–348, February 5, 2010 ª2010 Elsevier Inc.icantly higher than those in Pkr+/+ controls (Figure 6C). A similar
trend was also observed in hepatic glucose production (HGP)
levels, although this did not reach statistical significance (Fig-
ure 6D). Examination of insulin-stimulated tissue glucose uptake
revealed significant increase in muscle tissue of Pkr/ mice
compared to Pkr+/+ controls (Figure 6E). Although WAT glucose
uptake was not significantly different between genotypes,
a similar trend was also observed (Figure 6F). Under these con-
ditions, lipid infusion did not result in differential activation of
proapoptotic pathways between genotypes, indicating that the
reported apoptotic activity of PKRwas not an underlying contrib-
utor to the phenotype seen in the Pkr/mice (Figure S6). Taken
together these data clearly show that lipid-induced PKR
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Figure 6. PKR Mediates Lipid-Induced Insulin Resistance
(A–F) Hyperinsulinemic–euglycemic clamp studies performed in Pkr+/+ (n = 5) and Pkr/ mice (n = 5) infused with lipid for 5 hr. (A) Glucose infusion rates (GIR)
throughout the clamp procedure. (B) Average GIR. (C) Whole-body glucose disposal rates (Rd). (D) Hepatic glucose production (HGP) during the clamp. Tissue
glucose uptake in gastrocnemius muscle (E) and epididymal fat (F) tissues of Pkr+/+ and Pkr/ mice. Data are shown as the mean ± SEM. *p < 0.05.
See also Figure S6.activation is an important negative regulator of insulin action and
that PKR directly regulates insulin sensitivity in multiple settings.
DISCUSSION
Although the integration of nutrient and pathogen response
systems has been put forward as an attractive model to explain
the inflammatory origin of metabolic disease, identification of
specific molecules and mechanisms directly coordinating these
extensive links has been a major challenge (Hotamisligil and
Erbay, 2008). In this study, we uncovered a link between an
established pathogen-sensing pathway mediated by PKR and
metabolic homeostasis through regulation of JNK activity and
insulin action (Figure 7). This raises an intriguing possibility that
PKR may act as a central integrator in the inflammatory compo-
nent of metabolic control by linking nutrient- and pathogen-
sensing pathways.
One of the remaining important questions regarding the rela-
tionships between inflammatory pathways and insulin action is
how the action of many molecules with similar biological func-
tions are coordinated. Previous studies have shown direct inter-
actions of PKR with the IKKb-NF-kB pathway (Bonnet et al.,
2000). In this study, we have demonstrated PKR’s direct inter-
action and modulation of IRS, a critical molecule in insulin
action, and the major regulatory role over JNK activation. Taken
together, these findings make PKR a very attractive molecule atthe core of a complex that features major inflammatory and
stress roads that intersect with metabolism. As activation of
several stress signaling pathways produces similar outcomes
in metabolic regulation, the possibility that these molecules
work as part of a complex or a signaling node assembled and
coordinated by amolecule of innate immunity with direct nutrient
recognition potential is of critical importance. Such a role is high-
lighted for PKR in the integration of nutrient and pathogen
sensing in relation to metabolic homeostasis (Figure 7). In this
scenario, it is possible that the activity of one component is
highly regulated by the other, and thus amplified feedback
mechanisms may be in place. For example, the interaction and
function of JNK or IKK may also influence PKR and PKR activa-
tion, in turn contributing to organelle stress. Hence, we suggest
that PKRmay be critical in the assembly and activation of a puta-
tive metabolic inflammasome (or metaflammasome). These
interesting possibilities merit further investigation.
It is noteworthy that PKR responds to pathogens, nutrients,
and organelle stress. Then, PKR plays a role in the mounting of
adaptive and survival responses including suppression of
general protein translation through phosphorylation of eIF2a
and inhibition of anabolic effects of insulin action. The marked
increase in PKR activity observed in multiple models of obesity
featuring energy and nutrient excess may represent an adaptive
attempt to interfere with synthetic pathways that would further
accumulate energy. This is consistent with the late-onset effectsCell 140, 338–348, February 5, 2010 ª2010 Elsevier Inc. 345
Figure 7. Regulation of Systemic Metabolic Responses by PKR
PKR senses and responds to obesity, ER stress, and pathogen-related stress
in concert with JNK, leading to metabolic disease under diverse physiological
and pathological conditions. In this capacity, PKR not only integrates immune
andmetabolic response systems but also links endoplasmic reticulum homeo-
stasis and unfolded protein response (UPR) to translational regulation through
eIF2a and insulin signaling through IRS1. Finally, the kinases IRS1 and eIF2a
may represent a ‘‘metabolic inflammasome’’ complex assembled and regu-
lated by PKR.of PKR activity on adiposity. The function of PKR activation may
be limited to coordinated launching of an inflammatory response
together with kinases such as JNK and IKK, as supported by the
evidence provided in this study, which results in alterations in
insulin action and possibly other metabolic outcomes. The
most attractive implication of our observation is that PKR can
directly sense nutrients or other metabolic products including
endogenous RNA species produced during metabolic or ER
stress. This possibility is strongly supported by the observation
that PKR’s defined RNA-binding domain is required for its acti-
vation by lipids or ER stress (Figures 2G and 2H).
On the other hand, PKR’s ability to sense and respond to path-
ogens directly and to control the inflammatory output and meta-
bolic consequences illustrates the diversity of PKR-mediated
responses to both extrinsic and intrinsic stress signals. This
functional diversity also raises the possibility that the role of
PKR in metabolic regulation not only may be critical in dietary
exposures and insulin resistance but also may include other
metabolic abnormalities that emerge during the course of certain
infections. For example, both type 1 and type 2 diabetes have
been associated with viral infections, but mechanisms linking
viral infections to diabetes are not well understood (Antonelli
et al., 2009; von Herrath, 2009). It is known that one-third of
patients with chronic hepatitis C, which can trigger PKR activity,
develop type 2 diabetes (Bahtiyar et al., 2004; Delhem et al.,
2001; Tokumoto et al., 2007). Molecular mechanisms by which
b cells are destroyed during the development of type 1 diabetes
have also remained elusive, although recent studies suggest
a potential involvement of metabolic status, ER stress, and346 Cell 140, 338–348, February 5, 2010 ª2010 Elsevier Inc.inflammatory responses (Eizirik et al., 2008; Ron and Walter,
2007). As PKR modifies insulin signaling and contributes to
apoptosis induced by double-stranded RNA (Scarim et al.,
2001), it may offer critical insights into the pathogenesis of
both forms of diabetes and metabolic deregulation triggered
by viral infections.
Taken together with the previous reports, our results showing
that PKR can act in conjunction with major inflammatory kinases
and directly interact with a critical insulin signaling component
lead us to suggest PKR as a core component of a putative
‘‘metabolic inflammasome’’ that consists of major elements in
inflammatory signaling and insulin action (Figure 7). This PKR-
coordinated sensing and signaling complex may represent
a central mechanism for the integration of pathogen response
and innate immunity with insulin action and metabolic pathways
that are critical in chronic metabolic diseases. If small molecules
canmodulate in vivo PKR activity, therapeutic opportunities may
arise from such efforts.
EXPERIMENTAL PROCEDURES
Mice
Animal care and experimental procedures were performed with approval from
animal care committees of Harvard University. Two different types of targeted
mutations of PKR have been established and reported in mice, RNA-binding
domain-defective and kinase-domain-defective models (Abraham et al.,
1999; Baltzis et al., 2002; Yang et al., 1995). In this study, the kinase-
domain-defective PKR-deficient mice have been used. Male Pkr+/+ and
Pkr/ mice in the 129Sv 3 BALB/C mixed background (Abraham et al.,
1999) were kept on a 12 hr light/12 hr dark cycle and were placed on a HFD
(D12492: 60% kcal% fat; Research Diets), beginning at 3 weeks of age ad
libitum. After 6 and 14 weeks on HFD, GTTs were performed by intraperitoneal
glucose injection (1.5 g/kg) following an overnight food withdrawal. After
16 weeks on HFD, ITTs were performed by intraperitoneal insulin injection
(1 IU/kg) following 6 hr daytime food withdrawal. After 20 weeks, these mice
were sacrificed and tissues were collected for further analysis. Total body
fat mass was assessed by dual energy X-ray absorptiometry (DEXA; PIXImus).
For metabolic measurements, mice were placed in an indirect open circuit
calorimeter (Columbus Instruments). Serum insulin, leptin, and adiponectin
levels were measured with ELISA (Alpco). Liver triglycerides were determined
with a colorimetric system (Sigma-Aldrich) adapted for microtiter plate assays
(Furuhashi et al., 2007). Serum alanine aminotransferase level was measured
with Piccolo-lipid panel plus (Abaxis).
Hyperinsulinemic-Euglycemic Clamp Studies
Hyperinsulinemic-euglycemic clampswere conductedas previously described
(Furuhashi et al., 2007). For the lipid-induced acute insulin resistance mouse
model, 6-month-old male Pkr+/+ and Pkr/ mice were anesthetized and the
right jugular vein was catheterized with a PE-10 polyethylene tube filled with
heparin solution (100 U/ml) (United States Pharmacopeia). After a 3 day
recovery, overnight-fasted mice were preinfused with lipid (5 ml/kg/hr; Intrali-
pid; BaxterHealthcareCorporation) or saline for 3 hr followedby further infusion
withHPLCpurified 3H-glucose (0.05mCi/min;PerkinElmer) for 2 hrbasalperiod.
The Intralipid we used contains 20% Soybean oil. The Soybean oil is a refined
natural product consisting of amixture of neutral triglycerides of predominantly
linoleic, oleic, palmitic, linolenic, and stearic acids. After the basal period,
a 120 min hyperinsulinemic-euglycemic clamp was conducted with a primed-
continuous infusion of human insulin (Novolin; Novo Nordisk) at a rate of
12.5mU/kg/min.Bloodsampleswerecollectedat 20min intervals for the imme-
diate measurement of plasma glucose concentration, and 25% glucose was
infused at variable rates to maintain plasma glucose at basal concentrations.
Insulin-stimulated whole-body glucose disposal was estimated with a contin-
uous infusion of 3H-glucose throughout the clamps (0.1 mCi/min). To estimate
insulin-stimulated glucose uptake in individual tissues, 2-14C-deoxyglucose
(2-14C-DG; Perkin Elmer) was administered as a bolus (10 mCi) 75 min after the
start of clamps. Blood samples were collected for the determination of plasma
3H-glucose, 3H2O, and 2-
14C-DG concentrations. At the end of clamps,
muscles from both hindlimbs and epididymal adipose tissue were harvested
and immediately frozen in liquid N2 and stored at 80C until further analysis.
Calculations for the determination of metabolic parameters are described in
the Determination of Metabolic Parameters in Hyperinsulinemic-Euglycemic
Clamp Study section of the Extended Experimental Procedures.
Portal Vein Insulin Infusion and Protein Extraction from Tissues
Following 6 hr food withdrawal, mice were anesthetized and insulin (2 IU/kg)
or PBS was injected into mice through the portal vein. Three minutes
after injection, tissues were removed, frozen in liquid nitrogen, and kept at
80C until processing. For protein extraction, tissues were placed in a cold
lysis buffer (25 mM Tris-HCl [pH 7.4], 1 mM EGTA, 1 mM EDTA, 10 mM
Na4P2O7, 10 mM NaF, 2 mM Na3VO4, 1% NP-40, 1 mM PMSF, 1% protease
inhibitor cocktail [Sigma-Aldrich]). After homogenization on ice, the tissue
lysates were centrifuged, and the supernatants were used for western blot
analysis.
MEF Culture and Analysis
Primary Pkr+/+ and Pkr/ MEFs were used to assess phosphorylated JNK
level or JNK activity under palmitic acid, TNF-a, thapsigargin, or polyino-
sinic-polycytidylic acid stimulation. Both Pkr+/+ and Pkr/ cell lines were
established using the standard 3T3 immortalization protocol and used to
assess phosphorylation level of IRS1 and effects of PKR reconstitution on
insulin action. At 70%–80% confluency, cells were serum depleted for 3 hr
or overnight prior to the stimuli. Sodium palmitate was dissolved in water at
65C and prepared as 20 mM solution. In cell culture experiments, the
20 mM palmitic acid preparation was diluted with 0.5% BSA containing
DMEM to obtain the 0.5 mM palmitic acid concentration. Reagents and
recombinant cytokines were gently added to the culture dishes in the incu-
bator to prevent any environmental stress. For retrovirus production,
BOSC23 packaging cells were transfected at 70% confluence with Lipofect-
amine 2000 (Invitrogen) and a retroviral vector containing flag-tagged human
PKR coding region. After 48 hr, the viral supernatant was harvested and
filtered. Cells were incubated overnight with the viral supernatant, supple-
mented with 8 mg/ml polybrene. Expression vectors of adenovirus were con-
structed by cloning flag-tagged human PKR in adenovirus vector pAD/CMV/
V5-DEST, and the viruses were produced as described in Virapower adeno-
virus system (Invitrogen). Amplified-virus was used to infect primary Jnk1+/+
and Jnk1/ MEFs.
Kinase Assays
Tissue or cell lysates containing 100–300 mg of protein were mixed with
agarose-conjugated PKR antibody (Santa Cruz). The mixture was agitated at
4C, pelleted by centrifugation, and washed with lysis buffer followed by addi-
tional washes with PKR kinase buffer (15 mM HEPES [pH7.4], 10 mM MgCl2,
40 mM KCl, 2 mM DTT) for equilibration. The beads were incubated in kinase
buffer containing 10 mCi 32P-gATP (PerkinElmer) at 30C for 20min followed by
SDS-PAGE. To assess the phosphorylation of IRS1 by PKR, in vitro kinase
assays were performed with anti-PKR immunoprecipitates from lysates of
Pkr+/+ and Pkr/ MEFs, which were treated by TNF-a or thapsigargin. The
anti-PKR immunoprecipitates were mixed with IRS1, which was immunopuri-
fied with anti-IRS1 antibody (Upstate Biotechnology) from serum-starved WT
MEFs. Further procedures are provided in the PKR Kinase Assay with
Recombinant Protein section of the Extended Experimental Procedures.
Quantitative Real-Time PCR Analysis
Total RNA was isolated using Trizol reagent (Invitrogen). For reverse transcrip-
tion, total RNA was converted to first strand cDNA using a high capacity cDNA
reverse transcription system (Applied Biosystems). Quantitative real-time PCR
analysis was performed using SYBR Green in a real-time PCR machine (7300
Real Time PCR system; Applied Biosystems). Primers are listed in Table S1.
To normalize expression data of WAT and liver, 36B4 and GAPDH mRNAs
were used as an internal control gene, respectively.Statistical Analysis
The mean values for biochemical data from each group were compared by
Student’s t test. Comparisons between multiple time points were analyzed
using repeated-measures analysis of variance, ANOVA. In all tests, p < 0.05
was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and one table and can be found with this article online at doi:10.1016/
j.cell.2010.01.001.
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